ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026
Clinical predictors, microbiological profile, and outcomes of bacteremia in patients with cellulitis: a 6-year retrospective cohort study.
Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCellulitis is a common cause of hospital admission, yet the clinical relevance and predictors of bacteremia remain incompletely characterized. Identifying patients at risk of bloodstream infection may help optimize diagnostic strategies and clinical management.
methodsWe conducted a retrospective observational study at a tertiary-care hospital including all consecutive patients hospitalized with cellulitis between January 2019 and December 2024. Patients without blood cultures were excluded. Clinical severity was stratified using the CREST classification. Microbiological data, antibiotic therapy, hospital outcomes, and follow-up at 1 and 3 months were analyzed.
resultsAmong 311 episodes included, bacteremia was confirmed in 46 cases (14.8%). Patients with bacteremia showed significantly higher clinical severity at admission, with CREST grades III-IV present in 56.5% compared with 36.6% in non-bacteremia patients (p < 0.001). Sepsis occurred in 65.2% of bacteremia cases versus 24.5% of non-bacteremia cases (p < 0.001). Bacteremia was associated with longer hospital stay (18 ± 18.3 vs 13 ± 9.7 days; p = 0.003) and more frequent antibiotic modifications during admission (p = 0.023). Streptococcal species and Staphylococcus aureus showed a higher propensity for bloodstream invasion. In-hospital mortality was higher among bacteremia patients (13.0% vs 7.9%), although the difference was not statistically significant. Three-month mortality reached 14.3% in the bacteremia group compared with 9.9% in non-bacteremia patients.
conclusionBacteremia complicating cellulitis is uncommon but associated with greater clinical severity, longer hospitalization, and increased therapeutic complexity. Severity stratification tools such as CREST may assist in identifying patients at increased risk of bacteremia; however, given their limited discriminatory performance, they should not be used in isolation to guide blood culture collection or other clinical decisions.
Indexed as
Identifiers
42440220What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.